Aoxiang Pharmaceutical's announcement on applying for comprehensive credit lines from financial institutions in 2024
Aoxiang Pharmaceutical's announcement on the company's 2024 external guarantee amount forecast
Aoxiang Pharmaceutical's announcement on the use of some idle funds raised to temporarily supplement working capital
Aoxiang Pharmaceutical 2023 Audit Report
Inspection opinions of Guojin Securities Co., Ltd. on Zhejiang Aoxiang Pharmaceutical Co., Ltd.'s use of some idle funds raised to temporarily supplement working capital
Aoxiang Pharmaceutical Company Constitution
Aoxiang Pharmaceutical's announcement on holding a performance briefing for the first quarter of 2023 and 2024
Announcement of Resolutions of the 2nd Meeting of the 4th Supervisory Committee of Aoxiang Pharmaceutical
Aoxiang Pharmaceutical's announcement on renewing the 2024 Audit Institution
Aoxiang Pharmaceutical's Feasibility Analysis Report on Launching Foreign Exchange Derivatives Trading in 2024
Aoxiang Pharmaceutical's announcement on the use of idle funds raised for cash management
Opinions of Guojin Securities Co., Ltd. on the verification of the use of idle funds raised by Zhejiang Aoxiang Pharmaceutical Co., Ltd. for cash management
Special audit report on the summary table of Aoxiang Pharmaceutical's 2023 non-operating capital occupation and other related capital transactions
Aoxiang Pharmaceutical's 2023 Independent Director Debriefing Report (Luo Mingmin)
Aoxiang Pharmaceutical 2023 Fund Deposit and Use Verification Report
Aoxiang Pharmaceutical 2023 Internal Control Audit Report
Guojin Securities Co., Ltd.'s special inspection opinion on the storage and use of funds raised by Zhejiang Aoxiang Pharmaceutical Co., Ltd. in 2023
Aoxiang Pharmaceutical's 2023 Independent Director Debriefing Report (Yang Lirong)
Aoxiang Pharmaceutical's 2023 Independent Director Debriefing Report (Yang Shuxing)
Aoxiang Pharmaceutical's 2023 Independent Director Debriefing Report (Yang Zhishu - Resignation)
No Data